Trial Profile
Clinical Phase I/II Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Brain cancer; Glioblastoma; Glioma; Gliosarcoma
- Focus Diagnostic use
- Sponsors Medac
- 10 Apr 2018 New trial record